Projects funded by the NCN
A novel approach based on the optimized multidrug combination for glioblastoma treatment.
2020/39/D/NZ7/00789
Keywords:
glioblastoma multiforme inhibitors of receptor tyrosine kinases 3D cell culture CAM model orthotopic xenograft model drug repurposing
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
- NZ7_15: Toxicology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: SONATA 16 - announced on 2020-09-15
Amount awarded: 1 726 935 PLN
Project start date (Y-m-d): 2021-06-15
Project end date (Y-m-d): 2024-06-14
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.